These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2883176)

  • 21. Treatment of agitation following traumatic brain injury: a review of the literature.
    Levy M; Berson A; Cook T; Bollegala N; Seto E; Tursanski S; Kim J; Sockalingam S; Rajput A; Krishnadev N; Feng C; Bhalerao S
    NeuroRehabilitation; 2005; 20(4):279-306. PubMed ID: 16403996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Introduction: the clinical impact of agitation in various psychiatric disorders: management consensus and controversies.
    Mintzer JE
    J Clin Psychiatry; 2006; 67 Suppl 10():3-5. PubMed ID: 16965189
    [No Abstract]   [Full Text] [Related]  

  • 23. Beta blockers in neuroleptic-induced akathisia.
    Am J Psychiatry; 1988 Jul; 145(7):899-900. PubMed ID: 2898214
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapeutic use of carbamazepine for treatment of agitation and affective disorders in geriatric psychiatry patients].
    Lemke MR; Stuhlmann W
    Psychiatr Prax; 1994 Jul; 21(4):147-50. PubMed ID: 7938323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Akathisia: selective beta-blockers and rating instruments.
    Adler LA; Duncan E; Kim A; Hemdal P; Rotrosen J; Angrist B
    Psychopharmacol Bull; 1989; 25(3):451-6. PubMed ID: 2576321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Agitation as a possible expression of generalized anxiety disorder in demented elderly patients: toward a treatment approach.
    Mintzer JE; Brawman-Mintzer O
    J Clin Psychiatry; 1996; 57 Suppl 7():55-63; discussion 73-5. PubMed ID: 8690698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clozapine use in treatment-resistant agitation in the setting of dementia.
    Bastiampillai T; Dhillon R; French TH
    Aust N Z J Psychiatry; 2009 Jul; 43(7):689-90. PubMed ID: 19530027
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of the agitated demented elderly patient.
    Salzman C
    Hosp Community Psychiatry; 1988 Nov; 39(11):1143-4. PubMed ID: 2906318
    [No Abstract]   [Full Text] [Related]  

  • 29. Beta-adrenoceptor antagonists in neuropsychiatry: an update.
    Lader M
    J Clin Psychiatry; 1988 Jun; 49(6):213-23. PubMed ID: 2897959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clozapine for treatment-resistant agitation in dementia.
    Lee HB; Hanner JA; Yokley JL; Appleby B; Hurowitz L; Lyketsos CG
    J Geriatr Psychiatry Neurol; 2007 Sep; 20(3):178-82. PubMed ID: 17712102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Managing the agitated psychotic patient: a reappraisal of the evidence.
    Allen MH
    J Clin Psychiatry; 2000; 61 Suppl 14():11-20. PubMed ID: 11154012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Value of tiapride for agitation in the elderly. Review of published studies].
    Roger M; Gerard D; Leger JM
    Encephale; 1998; 24(5):462-8. PubMed ID: 9850821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review of agitation in mental illness: burden of illness and underlying pathology.
    Sachs GS
    J Clin Psychiatry; 2006; 67 Suppl 10():5-12. PubMed ID: 16965190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Naturalistic study of intramuscular ziprasidone versus conventional agents in agitated elderly patients: retrospective findings from a psychiatric emergency service.
    Kohen I; Preval H; Southard R; Francis A
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):240-5. PubMed ID: 16503319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-dose neuroleptics and neuroleptic rotation for agitated delirium near the end of life.
    Bascom PB; Bordley JL; Lawton AJ
    Am J Hosp Palliat Care; 2014 Dec; 31(8):808-11. PubMed ID: 24081790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of the elderly suffering from psychosis and dementia.
    Sunderland T
    J Clin Psychiatry; 1996; 57 Suppl 9():53-6. PubMed ID: 8823351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The treatment of disturbed behavior in patients with dementia].
    van de Boogerd ME; Pisters-van Roy AA; Wiertz YD
    Ned Tijdschr Geneeskd; 1992 Jul; 136(29):1419-20. PubMed ID: 1353612
    [No Abstract]   [Full Text] [Related]  

  • 38. [State of agitation. Diagnostic guidance and procedures in emergencies along with drug dosage recommendations].
    Haffen E; Sechter D
    Rev Prat; 1998 May; 48(10):1123-7. PubMed ID: 9781159
    [No Abstract]   [Full Text] [Related]  

  • 39. [Initial use of risperidone in the treatment of acutely exacerbated schizophrenic patients--an interim analysis].
    Pajonk FG; Schreiner A; Peters S; Rettig K; Degner D; Rüther E
    Fortschr Neurol Psychiatr; 2003 May; 71(5):249-54. PubMed ID: 12740756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of acute agitation in psychotic disorders.
    Mohr P; Pecenák J; Svestka J; Swingler D; Treuer T
    Neuro Endocrinol Lett; 2005 Aug; 26(4):327-35. PubMed ID: 16136016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.